Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × High Risk Prostate Cancer × Receptors, Androgen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

High Risk Prostate Cancer 1

Interventions

apalutamide 1 Receptors, Androgen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06758882 2025-01-06

STAPLE

A.O.U. Città della Salute e della Scienza

Phase 2 Recruiting

High Risk Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡